News

STAT1dOpinion
BridgeBio CEO: Congress must renew a popular, bipartisan FDA program benefiting sick kids
In Washington, even widely hailed programs with bipartisan support — like the rare pediatric disease priority review voucher ...
PipelineReview.com6d
BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor, in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors
SOUTH SAN FRANCISCO, CA, USA I April 01, 2025 I TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (“BBOT” or the “Company”), a clinical-stage ...
BridgeBio Pharma Sees Unusually Large Options Volume (NASDAQ:BBIO)
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) was the recipient of unusually large options trading on Monday. Traders acquired 8,235 call options on the stock. This is an increase of 88% ...
BridgeBio Pharma (NASDAQ:BBIO) Coverage Initiated at Redburn Atlantic
Equities research analysts at Redburn Atlantic began coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) in a research note issued on Monday, Marketbeat.com reports. The firm set a ...